Trexquant Investment’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-127,851
| Closed | -$876K | – | 1375 |
|
|
2023
Q3 | $876K | Buy |
+127,851
| New | +$876K | 0.02% | 799 |
|
|
2022
Q1 | – | Sell |
-14,587
| Closed | -$212K | – | 1297 |
|
|
2021
Q4 | $212K | Buy |
+14,587
| New | +$212K | 0.01% | 1118 |
|
|
2021
Q3 | – | Sell |
-13,555
| Closed | -$238K | – | 1087 |
|
|
2021
Q2 | $238K | Buy |
+13,555
| New | +$238K | 0.02% | 824 |
|
|
2018
Q2 | – | Sell |
-20,222
| Closed | -$354K | – | 860 |
|
|
2018
Q1 | $354K | Buy |
+20,222
| New | +$354K | 0.02% | 756 |
|
|
2017
Q4 | – | Sell |
-9,579
| Closed | -$247K | – | 1022 |
|
|
2017
Q3 | $247K | Buy |
+9,579
| New | +$247K | 0.06% | 536 |
|
|
2017
Q2 | – | Sell |
-6,755
| Closed | -$201K | – | 756 |
|
|
2017
Q1 | $201K | Buy |
+6,755
| New | +$201K | 0.03% | 955 |
|